- Home
- HMST vs XBIT Comparison
HMST vs XBIT Comparison
Compare HMST & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HMST
- XBIT
- Stock Information
- Founded
- HMST 1921
- XBIT 2005
- Country
- HMST United States
- XBIT United States
- Employees
- HMST N/A
- XBIT 90
- Industry
- HMST Major Banks
- XBIT Pharmaceuticals and Biotechnology
- Sector
- HMST Finance
- XBIT Health Care
- Exchange
- HMST Nasdaq
- XBIT Nasdaq
- Market Cap
- HMST 246.0M
- XBIT 93.0M
- IPO Year
- HMST 2012
- XBIT 2015
- Fundamental
- Price
- HMST $13.24
- XBIT $2.83
- Analyst Decision
- HMST Hold
- XBIT
- Analyst Count
- HMST 3
- XBIT 0
- Target Price
- HMST $14.17
- XBIT N/A
- AVG Volume (30 Days)
- HMST 68.7K
- XBIT 184.6K
- Earning Date
- HMST 07-28-2025
- XBIT 08-11-2025
- Dividend Yield
- HMST N/A
- XBIT N/A
- EPS Growth
- HMST N/A
- XBIT N/A
- EPS
- HMST N/A
- XBIT N/A
- Revenue
- HMST $78,454,000.00
- XBIT N/A
- Revenue This Year
- HMST $161.80
- XBIT N/A
- Revenue Next Year
- HMST $8.90
- XBIT N/A
- P/E Ratio
- HMST N/A
- XBIT N/A
- Revenue Growth
- HMST N/A
- XBIT N/A
- 52 Week Low
- HMST $8.41
- XBIT $2.50
- 52 Week High
- HMST $16.10
- XBIT $8.32
- Technical
- Relative Strength Index (RSI)
- HMST 64.81
- XBIT 46.44
- Support Level
- HMST $13.14
- XBIT $2.95
- Resistance Level
- HMST $13.67
- XBIT $3.32
- Average True Range (ATR)
- HMST 0.34
- XBIT 0.17
- MACD
- HMST 0.07
- XBIT 0.01
- Stochastic Oscillator
- HMST 83.12
- XBIT 40.24
About HMST HomeStreet Inc.
HomeStreet Inc is a commercial bank. It provides commercial loans and consumer loans including mortgage loans, deposit products, private banking, and cash management services. The company loan products include commercial business loans and agriculture loans, consumer loans, single family residential mortgages, loans secured by commercial real estate and construction loans for residential and commercial real estate projects.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.